Messenger Ribonucleic Acid Quality Monitoring Market Forecast Reveals Where Future Industry Value Will Be Created
Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Messenger Ribonucleic Acid Quality Monitoring Market Growth From $1.64 Billion In 2026 To $2.49 Billion By 2030 At A CAGR Of 11%
The market for messenger ribonucleic acid quality monitoring has seen significant expansion over the last few years. Its value is projected to climb from $1.47 billion in 2025 to $1.64 billion in 2026, reflecting a compound annual growth rate (CAGR) of 11.3%. This historical growth has been driven by the broadening scope of mRNA research applications, the initial uptake of analytical validation tools, the increase in academic and clinical research initiatives, the growing utilization of mRNA in vaccine creation, and the accessibility of specialized quality control reagents.
Over the coming years, the messenger ribonucleic acid quality monitoring market is projected to undergo substantial expansion, with its size anticipated to reach $2.49 billion by 2030, reflecting a compound annual growth rate (CAGR) of 11.0%. This forecasted growth is driven by several factors, including the widening of therapeutic mRNA development pipelines, heightened regulatory oversight of mRNA products, increased financial commitments to biopharmaceutical manufacturing, a growing uptake of real-time quality analytics, and the expansion of contract research and manufacturing services. Key trends shaping the forecast period encompass a greater adoption of standardized mRNA quality control protocols, expanded utilization of advanced analytical instrumentation, more widespread incorporation of automated quality monitoring systems, the broadening of regulatory compliance testing requirements, and a sharper emphasis on mRNA stability and integrity.
Download A Free Sample Report For Comprehensive Market Insights:
Messenger Ribonucleic Acid Quality Monitoring Market Expansion Supported By Key Demand Factors
The growing need for customized therapies is anticipated to boost the messenger ribonucleic acid quality monitoring market in the coming period. Personalized medicine involves treatments adjusted to a patient’s genetic profile, lifestyle, and environmental factors to achieve optimal therapeutic results. This rising demand stems from an increase in chronic and rare conditions, which require precisely targeted approaches for better treatment efficacy. Messenger ribonucleic acid quality monitoring plays a key role in verifying the precision, consistency, and effectiveness of mRNA-based treatments, thereby enabling the creation of reliable and safe personalized therapies. As an example, the Personalized Medicine Coalition, a US nonprofit organization, reported in February 2024 that the FDA approved 16 novel personalized treatments for rare diseases in 2023, a significant uptick from the six approvals seen in 2022. Consequently, the escalating demand for personalized medicines is fueling expansion in the messenger ribonucleic acid quality monitoring market.
Messenger Ribonucleic Acid Quality Monitoring Market Segments: Where Are The Largest Growth Opportunities?
The messenger ribonucleic acid quality monitoring market covered in this report is segmented –
1) By Type: Analytical Instruments, Reagents And Consumables, Software And Services
2) By Technology: Liquid Chromatography-Mass Spectrometry (LC-MS), Electrophoresis, Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Techniques, Other Technologies
3) By Application: Vaccine Development, Therapeutic Messenger Ribonucleic Acid Products, Gene Editing
4) By End User: Biopharmaceutical And Biotechnology Companies, Contract Development And Manufacturing Organizations (CDMOs), Contract Research Organizations (CROs) And Analytical Labs, Academic And Research Institutes Or Centers
Subsegments:
1) By Analytical Instruments: Benchtop Analyzers, Microfluidic Systems, Spectrophotometers, Capillary Electrophoresis Systems
2) By Reagents And Consumables: Ribonucleic Acid Extraction Kits, Complementary Deoxyribonucleic Acid Synthesis Kits, Fluorescent Probes, Quality Control Standards
3) By Software And Services: Data Analysis Software, Laboratory Information Management Systems, Consulting Services, Validation And Training Services
Messenger Ribonucleic Acid Quality Monitoring Market Growth Trends Influencing Competitive Dynamics
Key players within the messenger ribonucleic acid quality monitoring sector are directing their efforts toward the creation of advanced solutions, including benchtop instruments, that enable swift and precise evaluation of messenger ribonucleic acid quality characteristics. A benchtop instrument refers to a compact laboratory apparatus intended for carrying out particular analyses or experiments on a workbench, delivering ease, rapidity, and availability without necessitating large-scale machinery. To illustrate, in June 2024, InDevR Inc., a biotechnology and analytical instrumentation firm based in the United States, introduced 5’CapQ, a rapid benchtop assay designed to assess critical quality attributes (CQAs) of mRNA-based vaccines. This assay measures the integrity and 5’ capping efficiency of mRNA molecules within a timeframe of under two hours, merging these important quality indicators into one streamlined procedure. It operates by specifically capturing mRNA molecules that possess a 5’ cap and tagging the poly(A) tail with a fluorescent marker, thereby guaranteeing that only completely intact, capped mRNA—which is crucial for stability and protein synthesis—is measured. By delivering fast, quantitative, and user-friendly analysis, 5’CapQ assists in removing testing obstacles in mRNA vaccine production, eliminating the demand for specialized knowledge or prolonged processing durations.
Messenger Ribonucleic Acid Quality Monitoring Market Major Participants And Competitive Dynamics
Major companies operating in the messenger ribonucleic acid quality monitoring market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Lonza Group AG, Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Intertek Group plc, Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., WuXi Biologics (Cayman) Inc., QIAGEN N.V., Bio-Techne Corporation, Fujifilm Diosynth Biotechnologies, GenScript Biotech Corporation, Promega Corporation, Takara Bio Inc., Oxford Nanopore Technologies Ltd., Creative Biolabs Inc., Creative Diagnostics, Jena Bioscience GmbH.
Access The Complete Messenger Ribonucleic Acid Quality Monitoring Market Report:
Messenger Ribonucleic Acid Quality Monitoring Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the messenger ribonucleic acid quality monitoring market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the messenger ribonucleic acid quality monitoring market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
